Funding source: Department of Science and Technology of Sichuan Province
Award Identifier / Grant number: 2020YFS0107
Funding source: Health Department of Sichuan Province
Award Identifier / Grant number: 20PJ072
Acknowledgments
Thanks Eliot Wycoff, head of the American-owned Star Bridge Translation Company (Chinese business ID: 91510106MA68J7HD24) for editing this manuscript for readability.
-
Research funding: This study was supported by the Health Department of Sichuan Province [grant number 20PJ072] and the Department of Science and Technology of Sichuan Province [grant number 2020YFS0107].
-
Author contribution: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Informed consent was obtained from all individuals included in this study.
-
Ethical approval: The study was approved by the institutional review board of West China Second University Hospital in Chengdu, China.
References
1. Ruiz-Irastorza, G, Crowther, M, Branch, W, Khamashta, MA. Antiphospholipid syndrome. Lancet 2010;376:1498–509. https://doi.org/10.1016/s0140-6736(10)60709-x.Search in Google Scholar
2. Bender Atik, R, Christiansen, OB, Elson, J, Kolte, AM, Lewis, S, Middeldorp, S, et al.. ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open 2018;2018:hoy004. https://doi.org/10.1093/hropen/hoy004.Search in Google Scholar PubMed PubMed Central
3. Xu, J, Chen, D, Duan, X, Li, L, Tang, Y, Peng, B. The association between antiphospholipid antibodies and late fetal loss: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2019;98:1523–33. https://doi.org/10.1111/aogs.13665.Search in Google Scholar PubMed
4. Gao, R, Zeng, R, Qing, P, Meng, C, Cheng, K, Zhang, S, et al.. Antiphospholipid antibodies and pregnancy outcome of assisted reproductive treatment: a systematic review and meta-analysis. Am J Reprod Immunol 2021;84:e13470. https://doi.org/10.1111/aji.13470.Search in Google Scholar PubMed
5. De Carolis, S, Tabacco, S, Rizzo, F, Giannini, A, Botta, A, Salvi, S, et al.. Antiphospholipid syndrome: an update on risk factors for pregnancy outcome. Autoimmun Rev 2018;17:956–66. https://doi.org/10.1016/j.autrev.2018.03.018.Search in Google Scholar PubMed
6. Tektonidou, MG, Andreoli, L, Limper, M, Amoura, Z, Cervera, R, Costedoat-Chalumeau, N, et al.. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 2019;78:1296–304. https://doi.org/10.1136/annrheumdis-2019-215213.Search in Google Scholar PubMed
7. Cinquanta, L, Fontana, DE, Bizzaro, N. Chemiluminescent immunoassay Technology: what does it change in autoantibody detection? Auto Immun Highlights 2017;8:9. https://doi.org/10.1007/s13317-017-0097-2.Search in Google Scholar PubMed PubMed Central
8. Mahler, M, Bentow, C, Serra, J, Fritzler, MJ. Detection of autoantibodies using chemiluminescence technologies. Immunopharmacol Immunotoxicol 2016;38:14–20. https://doi.org/10.3109/08923973.2015.1077461.Search in Google Scholar PubMed PubMed Central
9. Pengo, V, Tripodi, A, Reber, G, Rand, JH, Ortel, TL, Galli, M, et al.. Update of the guidelines for lupus anticoagulant detection, subcommittee on lupus anticoagulant/antiphospholipid antibody of the scientific and standardisation committee of the international society on thrombosis and haemostasis. J Thromb Haemostasis 2009;7:1737–40. https://doi.org/10.1111/j.1538-7836.2009.03555.x.Search in Google Scholar PubMed
10. Yelnik, CM, Porter, TF, Branch, DW, Laskin, CA, Merrill, JT, Guerra, MM, et al.. Brief report: changes in antiphospholipid antibody titers during pregnancy: effects on pregnancy outcomes. Arthritis Rheumatol 2016;68:1964–9. https://doi.org/10.1002/art.39668.Search in Google Scholar PubMed PubMed Central
© 2022 Walter de Gruyter GmbH, Berlin/Boston